Intelligence Platform
Patents
Browse 71 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination wi
granted patentUS 12428489
Human PD-L2 antibodies and methods of use therefor
granted patentUS 12391734
PD-1 homing endonuclease variants, compositions, and methods of use
granted patentUS 12351633
PD-1 and PD-L1 binding agents
granted patentUS 12338269
IL-2 superagonists in combination with anti-PD-1 antibodies
granted patentUS 12325747
Human PD-L1 antibodies and methods of use therefor
granted patentUS 12286483
Method of treating cancer using CD137 antibodies and PD-1 antagonists
granted patentUS 12269886
Tetravalent bispecific antibody against PD-1 and PD-L1
granted patentUS 12187799
Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor
granted patentUS 12168688
Antibodies and variants thereof against PD-L1
granted patentUS 12134648
Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor
granted patentUS 12089575
Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
granted patentUS 12054557
Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat
granted patentUS 12053534
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
granted patentUS 12054556
Anti-PD-L1 antibody and use thereof
granted patentUS 12023355
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof
granted patentUS 12018015
Methods and compositions for targeting PD-L1
granted patentUS 11993655
Anti-PD-L1 antibody and use thereof
granted patentUS 11981736
Antibodies specific to glycosylated PD-1 and methods of use thereof
granted patentUS 11976128
Human PD-L2 antibodies and methods of use therefor
granted patentUS 11939581
Methods and compositions for targeting PD-L1
granted patentUS 11932692
Methods of treating cancer pain by administering a PD-1 inhibitor
granted patentUS 11926668
Anti-PD-1 antibodies for treatment of lung cancer
granted patentUS 11786553
Chimeric cytokine receptors bearing a PD-1 ectodomain
granted